ARTICLE | Company News
MediGene deal
October 11, 1999 7:00 AM UTC
MediGene acquired an exclusive worldwide license from inventor Horst Wolf to develop Etomoxir, a carnitine palmitoyl transferase 1 (CPT1) inhibitor that has completed Phase I testing to treat congest...